Endogenous chondroitin extends the lifespan and healthspan in C. elegans

Yukimasa Shibata,Yuri Tanaka,Hiroyuki Sasakura,Yuki Morioka,Toshihiro Sassa,Shion Fujii,Kaito Mitsuzumi,Masashi Ikeno,Yukihiko Kubota,Kenji Kimura,Hidenao Toyoda,Kosei Takeuchi,Kiyoji Nishiwaki
DOI: https://doi.org/10.1038/s41598-024-55417-7
IF: 4.6
2024-02-28
Scientific Reports
Abstract:Chondroitin, a class of glycosaminoglycan polysaccharides, is found as proteoglycans in the extracellular matrix, plays a crucial role in tissue morphogenesis during development and axonal regeneration. Ingestion of chondroitin prolongs the lifespan of C. elegans . However, the roles of endogenous chondroitin in regulating lifespan and healthspan mostly remain to be investigated. Here, we demonstrate that a gain-of-function mutation in MIG-22, the chondroitin polymerizing factor (ChPF), results in elevated chondroitin levels and a significant extension of both the lifespan and healthspan in C. elegans . Importantly, the remarkable longevity observed in mig-22(gf) mutants is dependent on SQV-5/chondroitin synthase (ChSy), highlighting the pivotal role of chondroitin in controlling both lifespan and healthspan. Additionally, the mig-22(gf) mutation effectively suppresses the reduced healthspan associated with the loss of MIG-17/ADAMTS metalloprotease, a crucial for factor in basement membrane (BM) remodeling. Our findings suggest that chondroitin functions in the control of healthspan downstream of MIG-17, while regulating lifespan through a pathway independent of MIG-17.
multidisciplinary sciences
What problem does this paper attempt to address?